Skip to main content

HOPA Abstracts

Imlunestrant With or Without Abemaciclib in Advanced Breast Cancer: Safety Analyses From the Phase 3 EMBER-3 Trial
Abstract #CR11
Emily Barrett, MSc
Read More
Assessment of Thromboprophylaxis Eligibility in Patients With Cancer at a Community Hospital
Abstract #CR12
Christopher Clayton, PharmD, BCOP; Sol Atienza, PharmD, BCOP
Read More
Prostate-Specific Antigen Response With Darolutamide Plus Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer in ARANOTE
Abstract #CR13
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, FHOPA
Read More
Pilot Study to Establish Incidence and Characteristics of Patients at Risk for Symptomatic Hyperammonemia Secondary to Recombinant Erwinia Asparaginase
Abstract #CR14
Catherine Martin, PharmD; Alexis Kuhn, PharmD, BCOP
Read More
CMV Reactivation With Bispecific Antibodies in Multiple Myeloma
Abstract #CR15
Jordan Snyder, PharmD, BCOP
Read More
Two-Year Real-World Patient-Reported Outcomes in Newly Diagnosed Patients With Immune Thrombotic Thrombocytopenic Purpura After Caplacizumab Plus Therapeutic Plasmatic Exchange Treatment: A Prospective, Observational Study
Abstract #CR16
Jennifer Wang, PharmD; Laurence Pollissard, MSc; Jennifer Wang; Marco Rossetti, BSBA; Synne Wing, MSW
Read More
Factors Associated With Clinical Outcomes in Patients With HER2 Mutation–Positive NSCLC Who Received Sevabertinib (BAY 2927088)
Abstract #CR17
Katelyn Toeniskoetter, PharmD, BCOP
Read More
SOHO-01: Safety and Efficacy of Sevabertinib in Patients With Advanced HER2 Mutation–Positive Non–Small Cell Lung Cancer Who Received Pretreatment but Were Naïve to HER2-Targeted Therapy or Had Not Received Any Treatment for Advanced Disease
Abstract #CR18
Katelyn Toeniskoetter, PharmD, BCOP
Read More
Automating Dose Rounding Within the Electronic Health Record: Impact on Drug Waste and Cost Avoidance
Abstract #CR19
Sarah Hogue, PharmD;
Read More
Treatment Persistence and Dose Modifications in US Patients With Hormone Receptor–Positive, HER2-Negative, Node-Positive, Early Breast Cancer Treated With Adjuvant Abemaciclib
Abstract #CR20
Astra Liepa, PharmD, BS
Read More
Page 2 of 15
Results 11 - 20 of 146